期刊文献+

广州地区1999~2003年鲍曼不动杆菌的耐药性调查 被引量:10

The Study of Antibiotic Resistance of Acinetobacter baumannii in Guangzhou during 1999~2003
在线阅读 下载PDF
导出
摘要 目的了解广州地区1999~2003年鲍曼不动杆菌耐药性及变化趋势,以指导临床合理用药。方法严格按照NCCLS的标准,用K-B法对从广州地区13家医院收集的鲍曼不动杆菌进行药物敏感性实验。用WHONET5软件进行资料统计,SPSS统计软件卡方检验进行统计学统计。结果1999~2003年不动杆菌对12种受试抗生素的耐药率分别是亚胺培南(IMP)7.3%~10.7%,阿米卡星(AMk)21.8%~34.1%,头孢匹美(FEP)21.4%~42.0%,头孢他啶(CAZ)26.2%~40.9%,左氧氟沙星(LEV)21.2%~43.0%,环丙沙星(CIP)36.0%~47.1%,庆大霉素(GEN)42.3%~48.9%,复方新诺明(SXT)39.0%~57.1%,哌拉西林(PIP)55.3%~67.0%,四环素(TEY)66.0%~81.0%,头孢噻肟(CTX)88.3%~90.8%及氨曲南(ATM)89.3%~97.1%。鲍曼不动杆菌对AMK、LEV、FEP、CIP、SXT、TEY、ATM的耐药性在1999~2003年间有差异(P<0.05),而对IMP、CAZ、GEN、PIP、CTX的耐药性无显著差异即无多大的变化(P>0.05)。结论IMP是广州地区治疗不动杆菌感染的最有效的抗生素。临床常用的各抗生素之间存在严重的交叉耐药,部分抗生素耐药性有上升趋势,临床应加强合理用药。 Objective To investigate the trend of antibiotic resistance of Acinetobacter baumannii(Abi )in Guangzhou during 1999~2003and to di rect clinical treatment.Methods Antimicrobial susceptibility test(AST)of Abi was done by K-B.The results were read according to the standard of NCCLS.T he data were processed by WHONET 5and the statistics were done by SPSS.Results During 1999~2003the rates of resistance of Abi to 12antibiotics respectively were Imipenem(IMP )7.3%~10.7%,Amikacin(AKM)21.8%~34.1%,Levofloxacin 21.2%~43.0%,Cefepime (FEP)21.4%~42.0%,Ceftazidime (CAZ)26.2%~40.9%,Ciproflozacin(CIP)36.0%~47.1%,Gentamycin(GEN)42.3%~48.9%,Sulfamethoxazole-Tr imethoprin(SXT)39.0%~57.1%,Piperacillin(PIP)55.3%~67.0%,Tetracycline(TET)66.0%~81.0%,Cefotaxiame (CTX)88.3%~90.8%,and Aztreonam(ATZ)89.3%~97.1%.Acinetobacter baumannii showed significant difference in th e resistance to AMK,LEV,FEP,CIP,SX T,TEY and ATM during1999~2003(P<0.05),but no significant difference to IM P,CAZ,GEN,PLP and CTX(P>0.05).Conclusions IMP is the valid classical antibiotics to Acinetobacter baumannii.There are relatively serious cross resistance among the antibiotics which are commonly used in clinical treatment in Guangzhou.There is a trend of increase in the resistance to some antibiotics.The clinical doctors should carefully u se antibiotics for treating the dise ase.
出处 《热带医学杂志》 CAS 2005年第2期203-204,202,共3页 Journal of Tropical Medicine
基金 广州市委科研重点攻关项目(No.2000-Z-027-01-2)。
关键词 鲍曼不动杆菌 耐药性 感染 变迁 Acinetobacter baumannii resistance infect change
  • 相关文献

参考文献3

二级参考文献11

  • 1[1]Brisse S, Milatovic D, Fluit A C. Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp using automated ribotyping [J]. J Clin Microbiol, 2000,38 (10): 3636
  • 2[2]Afzal-Shah M, Livermore D M. Worldwide emergence of carbapenem-resistant Acinetobacter spp[J] . J Antimicrob Chemother , 1998,41:576
  • 3[3]Robert E W. Resistant mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria [J]. Clin Infect Dis, 1998,27(Suppll): S93
  • 4[4]Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain [J]. Antimicrob Agents Chemother, 2000,44(6):1556
  • 5[5]Fernandez-viladrich P, Corbella X, Corral L, et al. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumanniiwith intraventricular colistim sulfomethate sodium[J].Clin Infect Dis, 1999,28(4) :916
  • 6Richardson H,传染病学最新资料,1997年,13卷,4页
  • 7www.ncbi.nlm.nih.gov/nucleotide.
  • 8Galimand M, Gerbaud G, Courvalin P. Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA[J]. Antimicrob Agent Chemother, 2000, 44(5): 1365-1366.
  • 9Jordi V, Joaquim R, Margarita N, et al. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain[J]. J Clin Microbiol, 1999, 37(3): 758-761.
  • 10陈东科,崔巧珍,胡云建.医院内不动杆菌流行现状及耐药性分析[J].中华流行病学杂志,2003,24(7):640-641. 被引量:27

共引文献298

同被引文献57

引证文献10

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部